NIH’s Translational Science Center Could See Budget Trimmed
Executive Summary
Republicans on appropriations subcommittee again seem concerned about whether NCATS will trample industry toes, which could lead to a more tightened focus for the new NIH center’s funding in the upcoming bill.
You may also be interested in...
US FDA Exploring Consortium To Develop Treatments For ‘Economically Infeasible’ Cancer Indications
The FDA could partner with industry, academia and advocacy groups to speed development of novel treatments for cancers that are not commercially viable.
NIH Appropriations Flat In House Subcommittee Mark, But Chair Calls It An Increase
Rep. Rehberg says focusing NIH spending on basic research instead of other purposes is effectively a boost; committee battles over funding for comparative effectiveness research.
NIH Translational Science Center Would Get 10% Funding Boost In Senate Bill
Appropriations Committee recommends BARDA receive a 12% increase over its fiscal 2012 appropriations in the report accompanying the Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations bill sent to the floor on a party-line vote of 16-14, June 14.